Records containing: Myelofibrosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-03-20In-Vivo Activated T-Cell Depletion to Prevent GVHD
-
CLINICAL_TRIALS study record update · 2011-05-04Evaluation of CEP-701, an Orally Available JAK2 Tyrosine Kinase Inhibitor, as a Therapy for Patients With Myelofibrosis
-
CLINICAL_TRIALS study record update · 2011-05-02A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators
-
CLINICAL_TRIALS study record update · 2011-04-28Creation of Bone Marrow Microenvironment for Treatment of MDS in Conjunction With Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2011-04-05A Phase 1 Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of XL019 Administered to Subjects With Myelofibrosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-03-30Phase II Study of Azacitidine in Myelofibrosis
-
CLINICAL_TRIALS study record update · 2011-02-21Phase II Study of CC-5013 in Myelofibrosis
-
CLINICAL_TRIALS study record update · 2009-10-26A Phase 1, Open-label, Dose-escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered TG101348 in Patients With Primary, Post-polycythemia Vera, or Post-essential Thrombocythemia Myelofibrosis
-
CLINICAL_TRIALS study record update · 2009-10-12Chart Review of Reduced Intensity Conditioning (RIC) Allogeneic Transplants in Elderly Patients With Myelofibrosis.